SummaryHims & Hers’ $49 Wegovy copy has triggered legal threats from Novo Nordisk, which calls it unsafe and illegal compounding. The dispute hit drug stocks, raised safety and patent concerns, and spotlighted tensions over cheaper GLP-1 alternatives as weight-loss pill competition intensifies in the US.